title: Comment on "Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate".
authors.affiliation: Health Publishing and Services Srl, Milan, Italy. rravasio@aboutpharma.com.
authors.forename: Roberto
authors.initials: R
authors.lastname: Ravasio
mesh_terms: D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid; D004359:Drug Therapy, Combination; D017048:Health Care Costs; D006801:Humans; D008727:Methotrexate; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate